Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 | Belimumab 10 mg/kg plus standard therapy | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
2 | Hetrombopag Olamine+Standard Therapy | [1] Hetrombopag Hetrombopag | - | - | - | [1] 60 60 |
3 | Other: Standard therapy | - | - | - | - | [1] 49 49 |
4 | RC18 160 mg plus standard therapy | - | - | - | - | [1] 49 49 |
5 | RC18 240 mg plus standard therapy | - | - | - | - | [1] 49 49 |
6 | RC18 80 mg plus standard therapy | - | - | - | - | [1] 49 49 |
7 | Standard therapy | - | - | - | - | [2] 49 49, 97 |
8 | Standard therapy (Excluding Immunosuppressants) | - | - | - | - | [1] 49 49 |
9 | Standard therapy (Including Immunosuppressants) | - | - | - | - | [1] 49 49 |
10 | Standard therapy (without eltrombopag): HD-DXM | [1] Eltrombopag Eltrombopag | - | - | - | [1] 63 63 |
11 | Standard therapy of septic shock | - | - | - | - | [1] 60 60 |